0001209191-23-022976.txt : 20230404
0001209191-23-022976.hdr.sgml : 20230404
20230404185643
ACCESSION NUMBER: 0001209191-23-022976
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230404
DATE AS OF CHANGE: 20230404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chee Conley
CENTRAL INDEX KEY: 0001883804
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37813
FILM NUMBER: 23800338
MAIL ADDRESS:
STREET 1: C/O SYROS PHARMACEUTICALS, INC.
STREET 2: 35 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001556263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453772460
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-744-1340
MAIL ADDRESS:
STREET 1: 35 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: LS22, Inc.
DATE OF NAME CHANGE: 20120815
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-31
0
0001556263
Syros Pharmaceuticals, Inc.
SYRS
0001883804
Chee Conley
C/O SYROS PHARMACEUTICALS, INC.
35 CAMBRIDGEPARK DRIVE
CAMBRIDGE
MA
02140
0
1
0
0
Chief Commercial Officer
0
Common Stock
2023-03-31
4
M
0
2000
A
2000
D
Common Stock
2023-04-03
4
F
0
658
2.58
D
1342
D
Restricted Stock Units
2023-03-31
4
M
0
2000
0.00
D
Common Stock
2000
6000
D
Represents shares of common stock received upon vesting of a restricted stock unit award.
On September 16, 2022, the issuer effected a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
Represents shares used to cover tax withholding on a restricted stock unit release.
Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
Represents a restricted stock unit award granted on February 15, 2022. These restricted stock units vest in four equal annual installments commencing on March 31, 2023.
/s/ Todd Rosenthal, as attorney-in-fact
2023-04-04